These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 20953695)

  • 1. Placental growth factor neutralising antibodies give limited anti-angiogenic effects in an in vitro organotypic angiogenesis model.
    Brave SR; Eberlein C; Shibuya M; Wedge SR; Barry ST
    Angiogenesis; 2010 Dec; 13(4):337-47. PubMed ID: 20953695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions.
    Carmeliet P; Moons L; Luttun A; Vincenti V; Compernolle V; De Mol M; Wu Y; Bono F; Devy L; Beck H; Scholz D; Acker T; DiPalma T; Dewerchin M; Noel A; Stalmans I; Barra A; Blacher S; VandenDriessche T; Ponten A; Eriksson U; Plate KH; Foidart JM; Schaper W; Charnock-Jones DS; Hicklin DJ; Herbert JM; Collen D; Persico MG
    Nat Med; 2001 May; 7(5):575-83. PubMed ID: 11329059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenovirus-mediated gene transfer of placental growth factor to perivascular tissue induces angiogenesis via upregulation of the expression of endogenous vascular endothelial growth factor-A.
    Roy H; Bhardwaj S; Babu M; Jauhiainen S; Herzig KH; Bellu AR; Haisma HJ; Carmeliet P; Alitalo K; Ylä-Herttuala S
    Hum Gene Ther; 2005 Dec; 16(12):1422-8. PubMed ID: 16390273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and localization of placenta growth factor and PlGF receptors in human meningiomas.
    Donnini S; Machein MR; Plate KH; Weich HA
    J Pathol; 1999 Sep; 189(1):66-71. PubMed ID: 10451490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell type- and tumor zone-specific expression of pVEGFR-1 and its ligands influence colon cancer metastasis.
    Jayasinghe C; Simiantonaki N; Kirkpatrick CJ
    BMC Cancer; 2015 Mar; 15():104. PubMed ID: 25880726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of angiogenic growth factor combinations on retinal endothelial cells.
    Castellon R; Hamdi HK; Sacerio I; Aoki AM; Kenney MC; Ljubimov AV
    Exp Eye Res; 2002 Apr; 74(4):523-35. PubMed ID: 12076096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of vascular endothelial growth factor receptor-1 sustains angiogenesis and Bcl-2 expression via the phosphatidylinositol 3-kinase pathway in endothelial cells.
    Cai J; Ahmad S; Jiang WG; Huang J; Kontos CD; Boulton M; Ahmed A
    Diabetes; 2003 Dec; 52(12):2959-68. PubMed ID: 14633857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor angiogenesis and anti-angiogenic therapies.
    Shahneh FZ; Baradaran B; Zamani F; Aghebati-Maleki L
    Hum Antibodies; 2013; 22(1-2):15-9. PubMed ID: 24284305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The vascular endothelial growth factors and receptors family: Up to now the only target for anti-angiogenesis therapy.
    Tarallo V; De Falco S
    Int J Biochem Cell Biol; 2015 Jul; 64():185-9. PubMed ID: 25936669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VEGFR-1-selective VEGF homologue PlGF is arteriogenic: evidence for a monocyte-mediated mechanism.
    Pipp F; Heil M; Issbrücker K; Ziegelhoeffer T; Martin S; van den Heuvel J; Weich H; Fernandez B; Golomb G; Carmeliet P; Schaper W; Clauss M
    Circ Res; 2003 Mar; 92(4):378-85. PubMed ID: 12600898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redundant roles of VEGF-B and PlGF during selective VEGF-A blockade in mice.
    Malik AK; Baldwin ME; Peale F; Fuh G; Liang WC; Lowman H; Meng G; Ferrara N; Gerber HP
    Blood; 2006 Jan; 107(2):550-7. PubMed ID: 16189273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placenta growth factor-1 antagonizes VEGF-induced angiogenesis and tumor growth by the formation of functionally inactive PlGF-1/VEGF heterodimers.
    Eriksson A; Cao R; Pawliuk R; Berg SM; Tsang M; Zhou D; Fleet C; Tritsaris K; Dissing S; Leboulch P; Cao Y
    Cancer Cell; 2002 Feb; 1(1):99-108. PubMed ID: 12086892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anti-vascular endothelial growth factor receptor-1 monoclonal antibody D16F7 inhibits invasiveness of human glioblastoma and glioblastoma stem cells.
    Atzori MG; Tentori L; Ruffini F; Ceci C; Lisi L; Bonanno E; Scimeca M; Eskilsson E; Daubon T; Miletic H; Ricci Vitiani L; Pallini R; Navarra P; Bjerkvig R; D'Atri S; Lacal PM; Graziani G
    J Exp Clin Cancer Res; 2017 Aug; 36(1):106. PubMed ID: 28797294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VEGF and PlGF: two pleiotropic growth factors with distinct roles in development and homeostasis.
    Tjwa M; Luttun A; Autiero M; Carmeliet P
    Cell Tissue Res; 2003 Oct; 314(1):5-14. PubMed ID: 13680354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor activity of a novel anti-vascular endothelial growth factor receptor-1 monoclonal antibody that does not interfere with ligand binding.
    Graziani G; Ruffini F; Tentori L; Scimeca M; Dorio AS; Atzori MG; Failla CM; Morea V; Bonanno E; D'Atri S; Lacal PM
    Oncotarget; 2016 Nov; 7(45):72868-72885. PubMed ID: 27655684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VEGF function for upregulation of endogenous PlGF expression during FGF-2-mediated therapeutic angiogenesis.
    Fujii T; Yonemitsu Y; Onimaru M; Inoue M; Hasegawa M; Kuwano H; Sueishi K
    Atherosclerosis; 2008 Sep; 200(1):51-7. PubMed ID: 18258238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of the angiogenic factors PlGF, VEGF and their receptors (Flt-1, Flk-1/KDR) by TSH in cultured thyrocytes and in the thyroid gland of thiouracil-fed rats suggest a TSH-dependent paracrine mechanism for goiter hypervascularization.
    Viglietto G; Romano A; Manzo G; Chiappetta G; Paoletti I; Califano D; Galati MG; Mauriello V; Bruni P; Lago CT; Fusco A; Persico MG
    Oncogene; 1997 Nov; 15(22):2687-98. PubMed ID: 9400995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro.
    Tille JC; Wood J; Mandriota SJ; Schnell C; Ferrari S; Mestan J; Zhu Z; Witte L; Pepper MS
    J Pharmacol Exp Ther; 2001 Dec; 299(3):1073-85. PubMed ID: 11714897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and characterization of a naturally occurring vascular endothelial growth factor.placenta growth factor heterodimer.
    DiSalvo J; Bayne ML; Conn G; Kwok PW; Trivedi PG; Soderman DD; Palisi TM; Sullivan KA; Thomas KA
    J Biol Chem; 1995 Mar; 270(13):7717-23. PubMed ID: 7706320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ranibizumab efficiently blocks migration but not proliferation induced by growth factor combinations including VEGF in retinal endothelial cells.
    Deissler HL; Deissler H; Lang GK; Lang GE
    Graefes Arch Clin Exp Ophthalmol; 2013 Oct; 251(10):2345-53. PubMed ID: 23760670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.